References
- Sullivan MP et al: Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained or radiotherapy (2,000 to 2,500 rads tumor dose) in treatment for meningeal leukemia. Cancer 35: 1066, 1975
- Sullivan MP et al: Combination intrathecal therapy for meningeal leukemia; two vs three drugs. American Association for Cancer Research, 66th Annual Meeting, San Diego, 1975 (abstract #340, p 85)
- Young D, Shapiro W, Posner J: Treatment of leptomeningeal cancer. Neurology 25: 370, 1975
- Willoughby WLN: Treatment of overt meningeal leukemia in children; results of second MRC meningeal leukemia trial. Br Med J 2: 864, 1976
- Posner JB: Reservoirs for intraventricular chemotherapy. N Engl J Med 288: 212, 1973
- Spiers ASD: Surgery in management of patients with leukemia. Br Med J 3: 528, 1973
- Shapiro W, Young D, Mehta B: Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular, and lumbar injections. N Engl J Med 293: 161, 1975
- Kay HEM et al: Encephalopathy in acute leukemia associated with methotrexate therapy. Arch Dis Child 47: 344, 1972
- Pochedly C: Leukemia and Lymphoma in the Nervous System. Charles C Thomas, Publisher, Springfield, Ill. 1976. (in press)